Skip to main content

Animations

MJFF Publications

2361 - 2370 of 9030 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Viewpoint on Milestones for Fellowship Training in Movement Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29146
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29131
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29077
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29027
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28659
    Citation Count: 2
  • Inhaled Levodopa as a Potential Treatment for Diphasic Dyskinesia
    2020
    Summary Details
    RESTRICTED
    Title: Inhaled Levodopa as a Potential Treatment for Diphasic Dyskinesia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28361
    Citation Count: 1
  • Tactile Temporal Discrimination Is Impaired in Myoclonus‐Dystonia
    2020
    Summary Details
    RESTRICTED
    Title: Tactile Temporal Discrimination Is Impaired in Myoclonus‐Dystonia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28253
    Citation Count: 1
  • Reply to: Diagnostic Delay in Cervical Dystonia‐Dystonia With Antecedent ET?
    2020
    Summary Details
    RESTRICTED
    Title: Reply to: Diagnostic Delay in Cervical Dystonia‐Dystonia With Antecedent ET?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28102
    Citation Count: 0
  • No Correlation Between White Matter Changes and Mild Parkinsonian Signs in Individuals Aged Older Than 75 Years
    2020
    Summary Details
    RESTRICTED
    Title: No Correlation Between White Matter Changes and Mild Parkinsonian Signs in Individuals Aged Older Than 75 Years
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28120
    Citation Count: 3
  • Corticobasal Degeneration Reveals Its Signature by Tau Strains
    2020
    Summary Details
    RESTRICTED
    Title: Corticobasal Degeneration Reveals Its Signature by Tau Strains
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28054
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.